Symbol="CRDF"
AssetType="Common Stock"
Name="Cardiff Oncology Inc"
Description="Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California."
CIK="1213037"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11055 FLINTKOTE AVENUE, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="76911000"
EBITDA="-40585000"
PERatio="None"
PEGRatio="None"
BookValue="2.16"
DividendPerShare="0"
DividendYield="0"
EPS="-0.89"
RevenuePerShareTTM="0.009"
ProfitMargin="0"
OperatingMarginTTM="-103.49"
ReturnOnAssetsTTM="-0.208"
ReturnOnEquityTTM="-0.344"
RevenueTTM="395000"
GrossProfitTTM="-26721000"
DilutedEPSTTM="-0.89"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.122"
AnalystTargetPrice="8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="159.97"
PriceToBookRatio="0.564"
EVToRevenue="482.74"
EVToEBITDA="-9.38"
Beta="1.698"
num_52WeekHigh="3.31"
num_52WeekLow="1.2"
num_50DayMovingAverage="1.552"
num_200DayMovingAverage="1.578"
SharesOutstanding="44677200"
DividendDate="2019-02-20"
ExDividendDate="None"
symbol="CRDF"
open="1.73"
high="1.73"
low="1.67"
price="1.69"
volume="106188.00"
latest_trading_day="2023-08-03"
previous_close="1.71"
change="-0.02"
change_percent="-1.1696%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="63"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="37"
Volume_recent_avg="172214"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.55"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="37"
Aroon_momentum_negative="63"
image_negative_thumbnail_id_1="175"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0001.jpeg"
image_negative_thumbnail_id_2="134"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0042.jpeg"
image_neutral_thumbnail_id_1="524"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_neutral_thumbnail_id_2="592"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_positive_thumbnail_id_1="959"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_positive_thumbnail_id_2="680"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0028.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
